Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices 89017 

• Section 418.76(k)(2), to address the 

requirement for instructions to be 

prepared by the interdisciplinary group. 

• Section 418.104(c), to include 

reference to 45 CFR parts 160 and 164. 

• Section 418.106(b)(1)(iii), to address 

this requirement to allow a physician 

assistant to order drugs in accordance 

with state scope of practice 

requirements and hospice policy. 

• Section 418.110(d)(2), to address 

the regulatory Life Safety Code (LSC) 

waiver requirement. 

• Section 418.110(d)(3), to address 

the requirement that the provisions of 

the adopted edition of the LSC do not 

apply in a State if we find that a fire and 

safety code imposed by State law 

adequately protects patients in hospices. 

• Section 418.110(e)(2), to address the 

Health Care Facilities Code waiver 

allowance. 

In addition to the standards review, 

we also reviewed CHAP’s comparable 

survey processes, which were 

conducted as described in section III. of 

this notice, and yielded the following 

areas where, as of the date of this notice, 

CHAP has completed revising its survey 

processes to demonstrate that it uses 

survey processes that are comparable to 

state survey agency processes by: 

• Revising CHAP’s surveyor guide to 

include comparable guidance relating to 

situations that might require 

discontinuation or refusal to conduct 

exit conference activities or share with 

CMS additional materials that are used 

by CHAP hospice program surveyors. 

• Revising CHAP’s surveyor guidance 

to be comparable with Appendix M 

related to inpatient hospice care. 

• Revising CHAP’s surveyor guide to 

include comparable guidance on 

reviewing personnel records for training 

requirements. 

• Revising CHAP’s Hospice 

Accreditation Processes and resources 

to include the applicable sections of the 

Health Care Facilities Code (HCFC) and 

National Fire Protection Agency (NFPA 

101) in accordance with § 418.110. 

• Ensuring that all Hospice LSC 

surveyors have received comparable, 

adequate training or have sufficient 

experience to make them qualified to 

survey health care facilities to both the 

2012 editions of LSC and HCFC, and 

2013 edition of the Fire Safety 

Evaluation System NFPA 101A Fire 

Safety for Health Care Occupancies. 

• Revising CHAP’s survey process to 

require pre-survey preparation to 

include review of the 2012 editions of 

the LSC and HCFC. 

• Revising CHAP’s LSC Survey 

Checklist and LSC citation 

documentation process to ensure all 

applicable regulations, LSC/HCFC 

sections, and CHAP standards are 

referenced in the survey report and 

provide surveyor training, as necessary. 

B. Term of Approval 

Based on our review and observations 

described in section III. of this final 

notice, we approve CHAP as a national 

accreditation organization for hospices 

that request participation in the 

Medicare program, effective November 

20, 2024 through November 20, 2029. 

V. Collection of Information 

Requirements 

This document does not impose 

information collection requirements, 

that is, reporting, recordkeeping or 

third-party disclosure requirements. 

Consequently, there is no need for 

review by the Office of Management and 

Budget under the authority of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. 3501 et seq.). 

The Administrator of the Centers for 

Medicare & Medicaid Services (CMS), 

Chiquita Brooks-LaSure, having 

reviewed and approved this document, 

authorizes Vanessa Garcia, who is the 

Federal Register Liaison, to 

electronically sign this document for 

purposes of publication in the Federal 

Register. 

Vanessa Garcia, 

Federal Register Liaison, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2024–26123 Filed 11–8–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–4040–0019] 

Agency Information Collection 

Request; 60-Day Public Comment 

Request 

AGENCY: Office of the Secretary, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before January 13, 2025. 

ADDRESSES: Submit your comments to 

sagal.musa@hhs.gov or by calling (202) 

205–2634. 

FOR FURTHER INFORMATION CONTACT: 

When submitting comments or 

requesting information, please include 

the document identifier 4040–0019–60D 

and project title for reference, to Sagal 

Musa, email: sagal.musa@hhs.gov, or 

call (202) 205–2634 the Reports 

Clearance Officer. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: Project 

Abstract Summary. 

Type of Collection: Extension. 

OMB No. 4040–0019. 

Abstract: The Project Abstract 

Summary form provides the Federal 

grant-making agencies an alternative to 

the Standard Form 424 data set and 

form. Agencies may use Project Abstract 

Summary form for grant programs not 

required to collect all the data that is 

required on the SF–424 core data set 

and form. Project Abstract Summary 

form is used by organizations to apply 

for Federal financial assistance in the 

form of grants. This form is evaluated by 

Federal agencies as part of the overall 

grant application. This IC expires on 

February 28, 2025. Grants.gov seeks a 

three-year clearance of these collections. 


khammond on DSKJM1Z7X2PROD with NOTICES
89018 Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices 

ANNUALIZED BURDEN HOUR TABLE

Forms (if necessary) Respondents (if necessary) Number of 

respondents 

Number of 

responses 

per 

respondents 

Average 

burden per 

response 

Total burden 

hours 

Project Abstract Summary ................ Grant applicants ............................... 3,467 1 1 3,467 

Total ........................................... ........................................................... 3,467 ........................ 1 3,467 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2024–26103 Filed 11–8–24; 8:45 am] 

BILLING CODE 4151–AE–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business-Anti-Infective Therapeutics. 

Date: December 4, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Marcus Ferrone, Pharm.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 402–2371, marcus.ferrone@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 23–064 

P01 Review: Translational Research on 

Antiretrovirals and Methamphetamine in the 

CNS. 

Date: December 4, 2024. 

Time: 2:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Raul Rojas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6185, 

Bethesda, MD 20892, (301) 451–6319, rojasr@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Social and Community Influences 

Across the Lifecourse. 

Date: December 5, 2024. 

Time: 10:30 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kate Fothergill, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3142, 

Bethesda, MD 20892, 301–435–1782, 

fothergillke@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–23– 

213: Interactive Digital Media Biomedical 

Science Resources for Pre-College Students 

and Teachers. 

Date: December 6, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Marie-Jose Belanger, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm. 6188, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1267, belangerm@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 5, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–26111 Filed 11–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

General Medical Sciences Council. 

The meeting will be held as a virtual 

meeting and open to the public, as 

indicated below. Individuals who plan 

to view the virtual meeting and need 

special assistance, such as sign language 

interpretation or other reasonable 

accommodations, should submit a 

request using the following link: https:// 

www.nigms.nih.gov/Pages/ 

ContactUs.aspx at least 5 days prior to 

the event. The open session will also be 

videocast, closed captioned, and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://

videocast.nih.gov). 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

General Medical Sciences Council. 

Date: February 6, 2025. 

Open: 9:30 a.m. to 12:30 p.m. 

Agenda: For the discussion of program 

policies and issues; opening remarks; report 

of the Director, NIGMS; and other business 

of the Council. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Closed: 1:30 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 


khammond on DSKJM1Z7X2PROD with NOTICES